@
placement:
NameDescriptionContent
Product Showcase
Bismuth Potassium Citrate
    Publish time 2024-09-06 15:44    

CAS NO.: 57644-54-9

Bismuth Potassium Citrate

Bismuth Potassium Citrate

Bismuth Potassium Citrate, also known as Potassium Bismuth Citrate Trihydrate or Colloidal Bismuth Subcitrate, is a commonly used medication for protecting the gastric mucosa.

Basic Information

  • English Name: Bismuth Potassium Citrate

  • Alternative Names: Potassium Bismuth Citrate, Colloidal Bismuth Subcitrate, De-Nol, Tripotassium Dicitrato-Bismuthate, etc.

  • CAS Number: 57644-54-9

  • EINECS Number: 260-872-5

  • Molecular Formula: C12H10BiK3O14

  • Molecular Weight: 704.47

Physical Properties

  • Appearance: White powder, salty taste, hygroscopic

  • Solubility: Highly soluble in water, very slightly soluble in ethanol

  • Nature: Its aqueous solution forms a colloidal solution with a slightly alkaline pH

Pharmacological Actions

  1. Gastric Mucosa Protection: Under the pH conditions of gastric juice, it forms a solid bismuth oxide colloid precipitate on the ulcer surface or at the base of the ulcer granulation tissue, serving as a protective film that isolates the ulcer mucosa from the erosive effects of gastric acid, enzymes, and food. This promotes the repair and healing of ulcer tissue.

  2. Anti-Pepsin Activity: It can complex with pepsin, rendering it inactive.

  3. Modification of Gastric Mucus Composition: It promotes the secretion of bicarbonate and mucus, prevents the degradation of mucus glycoproteins, and enhances the gastric mucosal barrier.

  4. Prevention of Hydrogen Ion Back Diffusion: Enhances the defensive capabilities of the gastric mucosa.

  5. Promotion of Prostaglandin Release: Stimulates the release of endogenous prostaglandins, increasing the concentration of prostaglandin E2 in the stomach and duodenal mucosa, thereby protecting the gastric mucosa.

  6. Eradication of Helicobacter Pylori (HP): Improves gastric mucosal blood flow, eradicates HP, and delays the development of HP resistance to antibiotics.